Track topics on Twitter Track topics that are important to you
ING Groep NV lowered its position in Bristol-Myers Squibb Co by 15.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 234,349 shares of the biopharmaceutical company's stock after selling 43,432 shares during the quarter.
Original Article: Bristol-Myers Squibb Co (BMY) Shares Sold by ING Groep NVNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...